相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development
Jordan H. Salas et al.
GASTROENTEROLOGY (2022)
Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
Victoria Stalls et al.
CELL REPORTS (2022)
Convergent antibody evolution and clonotype expansion following influenza virus vaccination
David Forgacs et al.
PLOS ONE (2021)
A cross-neutralizing antibody between HIV-1 and influenza virus
Chang-Chun D. Lee et al.
PLOS PATHOGENS (2021)
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Dapeng Li et al.
CELL (2021)
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
Sophie M-C Gobeil et al.
SCIENCE (2021)
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
Simone I. I. Richardson et al.
FRONTIERS IN IMMUNOLOGY (2021)
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies
Wilton B. Williams et al.
CELL (2021)
Serum IgA Fc effector functions in infectious disease and cancer
Samantha K. Davis et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin
Giuseppe A. Sautto et al.
JOURNAL OF IMMUNOLOGY (2020)
HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells
Cyril Planchais et al.
CELL REPORTS (2019)
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design
Zhen-Yong Keck et al.
PLOS PATHOGENS (2019)
Cross-Reactivity to Kynureninase Tolerizes B Cells That Express the HIV-1 Broadly Neutralizing Antibody 2F5
Joel Finney et al.
JOURNAL OF IMMUNOLOGY (2019)
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
Christine A. Bricault et al.
CELL HOST & MICROBE (2019)
High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity
Ian Setliff et al.
CELL (2019)
Cross-reactivity of HIV vaccine responses and the microbiome
Wilton B. Williams et al.
CURRENT OPINION IN HIV AND AIDS (2018)
HCV adaptation to HIV coinfection
James Lara et al.
INFECTION GENETICS AND EVOLUTION (2018)
Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design
Joel Finney et al.
RETROVIROLOGY (2018)
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
Valentine U. Chukwuma et al.
PLOS ONE (2018)
Host controls of HIV broadly neutralizing antibody development
Garnett Kelsoe et al.
IMMUNOLOGICAL REVIEWS (2017)
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
Patrick Ingiliz et al.
JOURNAL OF HEPATOLOGY (2017)
Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope
Brian G. Pierce et al.
JOURNAL OF VIROLOGY (2017)
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Ali Punjani et al.
NATURE METHODS (2017)
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs
Marianne Martinello et al.
CURRENT HIV/AIDS REPORTS (2017)
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance
Justin R. Bailey et al.
JCI INSIGHT (2017)
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance
Richard A. Urbanowicz et al.
JOURNAL OF VIROLOGY (2016)
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Dennis R. Burton et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
Lucy Platt et al.
LANCET INFECTIOUS DISEASES (2016)
Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection
Rena D. Astronomo et al.
EBIOMEDICINE (2016)
Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data
Namita T. Gupta et al.
BIOINFORMATICS (2015)
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
Pavel Pugach et al.
JOURNAL OF VIROLOGY (2015)
Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies
Wilton B. Williams et al.
SCIENCE (2015)
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
Joseph G. Jardine et al.
SCIENCE (2015)
Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding
Linling He et al.
SCIENTIFIC REPORTS (2015)
Polyreactivity and Autoreactivity among HIV-1 Antibodies
Mengfei Liu et al.
JOURNAL OF VIROLOGY (2015)
Hepatitis C virus (HCV)-specific memory B-cell responses in transiently and chronically infected HIV positive individuals
Sven Reiche et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
Marcella Sarzotti-Kelsoe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Antibodies VRC01 and 10E8 Neutralize HIV-1 with High Breadth and Potency Even with Ig-Framework Regions Substantially Reverted to Germline
Ivelin S. Georgiev et al.
JOURNAL OF IMMUNOLOGY (2014)
Emergence of Broadly Neutralizing Antibodies and Viral Coevolution in Two Subjects during the Early Stages of Infection with Human Immunodeficiency Virus Type 1
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2014)
Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination
Laurent Verkoczy et al.
CURRENT OPINION IN HIV AND AIDS (2014)
Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies
Giuseppe Sautto et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Pathogenesis of Accelerated Fibrosis in HIV/HCV Co-infection
Wenyu Lin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Global control of hepatitis C: where challenge meets opportunity
David L. Thomas
NATURE MEDICINE (2013)
Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection
Thijs Feuth et al.
PLOS ONE (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Polyreactive antibodies in adaptive immune responses to viruses
Hugo Mouquet et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS
Pornpun Vivithanaporn et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
Erick Giang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM
Femke A. E. Lambers et al.
AIDS (2011)
DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4
Karolin Hijazi et al.
PLOS ONE (2011)
HIV/hepatitis C coinfection natural history and disease progression
Maria D. Hernandez et al.
CURRENT OPINION IN HIV AND AIDS (2011)
HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies
Eva A. Operskalski et al.
Current HIV/AIDS Reports (2011)
Immune Evasion and Counteraction of Restriction Factors by HIV-1 and Other Primate Lentiviruses
Frank Kirchhoff
CELL HOST & MICROBE (2010)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Davide Corti et al.
PLOS ONE (2010)
Scaffolding to build a rational vaccine design strategy
Dennis R. Burton
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Elicitation of structure-specific antibodies by epitope scaffolds
Gilad Ofek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0
Stephane Guindon et al.
SYSTEMATIC BIOLOGY (2010)
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2009)
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Lei Chen et al.
SCIENCE (2009)
Impact of HIV on host-virus interactions during early hepatitis C virus infection
M. Danta et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Clinical progression of hepatitis C virus -: Related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active Antiretroviral therapy
Juan A. Pineda et al.
HEPATOLOGY (2007)
The epidemiology of hepatitis C infection in the United States
Vinod K. Rustgi
JOURNAL OF GASTROENTEROLOGY (2007)
Bacterial adhesion and entry into host cells
J Pizarro-Cerdá et al.
CELL (2006)
Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype
B Chohan et al.
JOURNAL OF VIROLOGY (2005)
Immune evasion versus recovery after acute hepatitis C virus infection from a shared source
I Tester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR
S Pöhlmann et al.
JOURNAL OF VIROLOGY (2003)
DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus
S Pöhlmann et al.
JOURNAL OF VIROLOGY (2001)
分享论文
